Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues
暂无分享,去创建一个
Xiangyu Li | Zheng Guo | Yawei Li | Juan Zhang | Jun He | Hao Cai | Yunyan Gu | Lishuang Qi | Haiyan Huang | Qingzhou Guan | Haidan Yan | You Guo | Yunyan Gu | Zheng Guo | You-min Guo | Jun He | L. Qi | Qingzhou Guan | Haidan Yan | H. Cai | Xiangyu Li | Haiyan Huang | Yawei Li | Juan Zhang
[1] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[2] P Barbry,et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity , 2011, Cell Death and Differentiation.
[3] A K Bahn,et al. Application of binomial distribution to medicine: comparison of one sample proportion to an expected proportion (for small samples). Evaluation of a new treatment. Evaluation of a risk factor. , 1969, Journal of the American Medical Women's Association.
[4] N. L. Johnson,et al. Breakthroughs in Statistics , 1992 .
[5] Qiang Sun,et al. Individual-level analysis of differential expression of genes and pathways for personalized medicine , 2015, Bioinform..
[6] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[7] Zheng Guo,et al. Separate enrichment analysis of pathways for up- and downregulated genes , 2014, Journal of The Royal Society Interface.
[8] Na Li,et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples , 2016, Oncotarget.
[9] Li-Jen Su,et al. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis. , 2014, Cellular signalling.
[10] Chen-Ching Lin,et al. Regulation rewiring analysis reveals mutual regulation between STAT1 and miR-155-5p in tumor immunosurveillance in seven major cancers , 2015, Scientific Reports.
[11] K. Macleod,et al. Mitochondrial Dysfunction in Cancer , 2013, Front. Oncol..
[12] Gideon Rechavi,et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] David Petersen,et al. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[14] Hsien-Da Huang,et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..
[15] J. Rice. Mathematical Statistics and Data Analysis , 1988 .
[16] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] James Bailey,et al. MIRAGAA - a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer , 2010, Bioinform..
[18] Charles M Perou,et al. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.
[19] Gregory W. Corder,et al. Tests for Nominal Scale Data: Chi‐Square and Fisher Exact Test , 2011 .
[20] Andreas Hierholzer,et al. Wnt/β-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells , 2012, Science.
[21] Laurence Zitvogel,et al. Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.
[22] R. Stephens,et al. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. , 2008, Cancer research.
[23] Igor Jurisica,et al. Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology , 2014, BMC Cancer.
[24] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[25] Chen-Ching Lin,et al. A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modules. , 2015, Molecular bioSystems.
[26] Z. Zhao,et al. Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicine , 2016, Oncogenesis.
[27] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[28] Jing Zhu,et al. GO-function: deriving biologically relevant functions from statistically significant functions , 2012, Briefings Bioinform..
[29] Tao Yang,et al. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. , 2014, Biochemical and biophysical research communications.
[30] Luca Esposito,et al. Lung Cancer: Are we up to the Challenge? , 2010, Current genomics.
[31] X Wang,et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.
[32] Yanyan Huang,et al. An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers , 2011, PloS one.
[33] Bo Liu,et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.
[34] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[35] D. Cox. Regression Models and Life-Tables , 1972 .
[36] Fang Zhou,et al. A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis , 2011, Clinical Cancer Research.
[37] Nicholas T. Ingolia,et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.
[38] Quaid Morris,et al. Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction , 2013, Genome Medicine.
[39] Masahiro Aoki,et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. , 2011, Cancer cell.
[40] Wei Jiang,et al. Systematic dissection of dysregulated transcription factor–miRNA feed-forward loops across tumor types , 2015, Briefings Bioinform..
[41] Hua Han,et al. Notch signaling pathway and cancer metastasis. , 2012, Advances in experimental medicine and biology.
[42] Hans Clevers,et al. Wnt/β-Catenin Signaling and Disease , 2012, Cell.
[43] Xin Huang,et al. MiR-210--micromanager of the hypoxia pathway. , 2010, Trends in molecular medicine.
[44] J. Marioni,et al. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts , 2016, Genome Biology.
[45] Ali Bashir,et al. Designing deep sequencing experiments: detecting structural variation and estimating transcript abundance , 2009, BMC Genomics.
[46] Elias Campo Guerri,et al. International network of cancer genome projects , 2010 .
[47] Xin Xu,et al. MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. , 2013, Biochemical and biophysical research communications.
[48] Zheng Guo,et al. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms , 2016, Oncotarget.
[49] Zheng Guo,et al. Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments , 2015, Scientific Reports.
[50] Trey Ideker,et al. Analysis of Matched Tumor and Normal Profiles Reveals Common Transcriptional and Epigenetic Signals Shared across Cancer Types , 2015, PloS one.